AccessPak for HIV PEP Expanded with Kaletra and Reteplase, recombinant Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Reteplase, recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: reteplase
Brand name: Retavase, Retavase Half-Kit
Synonyms: Reteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Retin A
- AccessPak for HIV PEP Expanded with Kaletra-Retin-A (Tretinoin Cream)
- AccessPak for HIV PEP Expanded with Kaletra-Retin-A (Tretinoin Gel)
- AccessPak for HIV PEP Expanded with Kaletra-Retin-A Cream, Gel, Liquid
- AccessPak for HIV PEP Expanded with Kaletra-Retin-A Micro
- AccessPak for HIV PEP Expanded with Kaletra-Retin-A Micro Topical
- Reteplase, recombinant Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Reteplase, recombinant Intravenous-Accolate
- Reteplase, recombinant Intravenous-Accretropin
- Reteplase, recombinant Intravenous-Accucaine
- Reteplase, recombinant Intravenous-AccuHist Drops
- Reteplase, recombinant Intravenous-AccuHist PDX Drops